
Adult Immunization
Latest News

FDA Approves Updated Prescribing Information for Inhaled Insulin Powder, Including New Starting Dose Guidance

FDA Clears First At-Home 4-in-1 Respiratory Test Detecting RSV, Influenza A/B, and COVID-19 in Infants, Adults

Caregiver Education on Alzheimer Agitation Is Essential: A Q&A with Geriatric Nurse Practitioner Carolyn Clevenger

Healthiest States in America: A 2025 Ranking

Nationwide Survey Finds Widespread Concern About Topical Steroid Use, Emphasizes Need for Long-Term Management Strategies in Chronic Inflammatory Skin Disease
Shorts










Latest Videos
Podcasts
Screening
Continuing Medical Education
All News

Sebela Pharmaceuticals seeks FDA approval for tegoprazan, a new treatment for GERD, targeting heartburn, erosive esophagitis, and maintenance healing.

A study reveals that using population-based eGFR percentiles can enhance early detection of chronic kidney disease and improve patient outcomes.

Your daily dose of the clinical news you may have missed.

This episode reviews intranasal epinephrine use, pediatric atopic dermatitis data, dementia screening tools, adolescent TMS, and oral PCSK9 therapy.

New phase 3 data reveals lumateperone significantly boosts remission rates in adults with major depressive disorder, offering hope for lasting relief.

Your daily dose of the clinical news you may have missed.

Gus Alva, MD, previews 2026 research directions and explains why sleep assessment and sleep disorders may become a bigger focus in routine care.

Results from the SPACE clinical trial showed fremanezumab reduced monthly migraine days versus placebo in children and adolescents with episodic migraine.

Your daily dose of the clinical news you may have missed.














































































































































